COVID-19: EU Regulators To Restrict Veklury Use

The European Medicines Agency has clarified in which COVID-19 patients Gilead’s antiviral should be used.

COVID-19
The EMA has recommended changing Veklury's indication • Source: Shutterstock

The European Medicines Agency wants to include a restriction to the indication for Veklury (remdesivir), Gilead Sciences’ COVID-19 treatment that was fast-tracked and approved conditionally in the EU a few months ago.

The agency has recommended changing the drug's indication to make it clearer in which COVID-19 patients requiring supplemental oxygen the...

More from Europe

More from Geography